Literature DB >> 19370762

Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype-phenotype correlations.

Jordan P Lerner-Ellis1, Natascia Anastasio, Junhui Liu, David Coelho, Terttu Suormala, Martin Stucki, Amanda D Loewy, Scott Gurd, Elin Grundberg, Chantal F Morel, David Watkins, Matthias R Baumgartner, Tomi Pastinen, David S Rosenblatt, Brian Fowler.   

Abstract

Methylmalonic aciduria and homocystinuria, cblC type, is a rare disorder of intracellular vitamin B(12) (cobalamin [Cbl]) metabolism caused by mutations in the MMACHC gene. MMACHC was sequenced from the gDNA of 118 cblC individuals. Eleven novel mutations were identified, as well as 23 mutations that were observed previously. Six sequence variants capture haplotype diversity in individuals across the MMACHC interval. Genotype-phenotype correlations of common mutations were apparent; individuals with c.394C>T tend to present with late-onset disease whereas patients with c.331C>T and c.271dupA tend to present in infancy. Other missense variants were also associated with late- or early-onset disease. Allelic expression analysis was carried out on human cblC fibroblasts compound heterozygous for different combinations of mutations including c.271dupA, c.331C>T, c.394C>T, and c.482G>A. The early-onset c.271dupA mutation was consistently underexpressed when compared to control alleles and the late-onset c.394C>T and c.482G>A mutations. The early-onset c.331C>T mutation was also underexpressed when compared to control alleles and the c.394C>T mutation. Levels of MMACHC mRNA transcript in cell lines homozygous for c.271dupA, c.331C>T, and c.394C>T were assessed using quantitative real-time RT-PCR. Cell lines homozygous for the late onset c.394C>T mutation had significantly higher levels of transcript when compared to cell lines homozygous for the early-onset mutations. Differential or preferential MMACHC transcript levels may provide a clue as to why individuals carrying c.394C>T generally present later in life. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19370762     DOI: 10.1002/humu.21001

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  69 in total

1.  Clinical, biochemical, and molecular analysis of combined methylmalonic acidemia and hyperhomocysteinemia (cblC type) in China.

Authors:  Fei Wang; Lianshu Han; Yanling Yang; Xuefan Gu; Jun Ye; Wenjuan Qiu; Huiwen Zhang; Yafen Zhang; Xiaolan Gao; Yu Wang
Journal:  J Inherit Metab Dis       Date:  2010-10-06       Impact factor: 4.982

2.  Cobalamin C deficiency in an adolescent with altered mental status and anorexia.

Authors:  Maria H Rahmandar; Amanda Bawcom; Mary E Romano; Rizwan Hamid
Journal:  Pediatrics       Date:  2014-11-03       Impact factor: 7.124

3.  The MMACHC proteome: hallmarks of functional cobalamin deficiency in humans.

Authors:  Luciana Hannibal; Patricia M DiBello; Michelle Yu; Abby Miller; Sihe Wang; Belinda Willard; David S Rosenblatt; Donald W Jacobsen
Journal:  Mol Genet Metab       Date:  2011-03-24       Impact factor: 4.797

4.  Hydrocephalus in cblC type methylmalonic acidemia.

Authors:  Kaihui Zhang; Min Gao; Guangyu Wang; Yingying Shi; Xiaoying Li; Yvqiang Lv; Guangye Zhang; Zhongtao Gai; Yi Liu
Journal:  Metab Brain Dis       Date:  2018-12-19       Impact factor: 3.584

5.  Neonatal atypical hemolytic uremic syndrome due to methylmalonic aciduria and homocystinuria.

Authors:  Francesca Menni; Sara Testa; Sophie Guez; Gabriella Chiarelli; Luisella Alberti; Susanna Esposito
Journal:  Pediatr Nephrol       Date:  2012-03-25       Impact factor: 3.714

Review 6.  Renal dysfunction in methylmalonic acidurias: review for the pediatric nephrologist.

Authors:  Marina A Morath; Friederike Hörster; Sven W Sauer
Journal:  Pediatr Nephrol       Date:  2012-07-20       Impact factor: 3.714

7.  Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte.

Authors:  James D Weisfeld-Adams; Mark A Morrissey; Brian M Kirmse; Bobbie R Salveson; Melissa P Wasserstein; Peter J McGuire; Sherlykutty Sunny; Jessica L Cohen-Pfeffer; Chunli Yu; Michele Caggana; George A Diaz
Journal:  Mol Genet Metab       Date:  2009-09-27       Impact factor: 4.797

8.  Cognitive and social profiles in two patients with cobalamin C disease.

Authors:  M H Beauchamp; V Anderson; A Boneh
Journal:  J Inherit Metab Dis       Date:  2009-10-15       Impact factor: 4.982

Review 9.  Genetic disorders of vitamin B₁₂ metabolism: eight complementation groups--eight genes.

Authors:  D Sean Froese; Roy A Gravel
Journal:  Expert Rev Mol Med       Date:  2010-11-29       Impact factor: 5.600

10.  Thermolability of mutant MMACHC protein in the vitamin B12-responsive cblC disorder.

Authors:  D S Froese; S Healy; M McDonald; G Kochan; U Oppermann; F H Niesen; R A Gravel
Journal:  Mol Genet Metab       Date:  2010-02-15       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.